Ching Sung Hsu
Chairman at Formosa Lithium Iron Oxide Corp.
Ching Sung Hsu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Formosa Lithium Iron Oxide Corp. | Chairman | - | - |
Career history of Ching Sung Hsu
Former positions of Ching Sung Hsu
| Companies | Position | Start | End |
|---|---|---|---|
| TAIWAN LEADER BIOTECH CORP. | Director/Board Member | 2009-03-05 | 2017-03-29 |
| UBI PHARMA INC. | Director/Board Member | 2015-03-25 | - |
| UNITED BIOPHARMA INC | Director/Board Member | 2013-11-14 | - |
| CHANGS ASCENDING ENTERPRISE CO., LTD. | Director/Board Member | - | - |
Training of Ching Sung Hsu
| Feng Chia University | Undergraduate Degree |
Statistics
International
| Taiwan | 7 |
Operational
| Director/Board Member | 4 |
| Undergraduate Degree | 1 |
| Chairman | 1 |
Sectoral
| Health Technology | 4 |
| Producer Manufacturing | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| CHANGS ASCENDING ENTERPRISE CO., LTD. | Producer Manufacturing |
| TAIWAN LEADER BIOTECH CORP. | Health Technology |
| UBI PHARMA INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Formosa Lithium Iron Oxide Corp. | |
United BioPharma, Inc.
 United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Ching Sung Hsu
- Experience
